Remoxy's Abuse Liability Study May Offer Clues On FDA's Upcoming Opioid Guidance

FDA’s response to new data on Remoxy could serve as a model for how the agency expects to deal with the abuse-deterrent formulations it is encouraging for oxycodone and other opioids.